MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 165301 to 165320 of 166,322 approvalsPage 8266 of 8317

Ambroxol Hydrochloride Injection

Approval Number: 国药准字H20193243
Registration: Aug 29, 2019

Oxiracetam Injection

Approval Number: 国药准字H20193237
Registration: Aug 29, 2019

宝宝牛黄散

Approval Number: 国药准字Z45022010
Registration: Aug 29, 2019

Bromfenac Sodium Eye Drops

Approval Number: 国药准字H20193244
Registration: Aug 29, 2019

Oxygen

Approval Number: 国药准字H20193240
Registration: Aug 29, 2019

Parecoxib Sodium for Injection

Approval Number: 国药准字H20193249
Registration: Aug 29, 2019

Oxygen

Approval Number: 国药准字H20193250
Registration: Aug 29, 2019

Ambroxol Hydrochloride Injection

Approval Number: 国药准字H20193242
Registration: Aug 29, 2019

Parecoxib Sodium for Injection

Approval Number: 国药准字H20193248
Registration: Aug 29, 2019

Sterile Water for Injection

Approval Number: 国药准字H43021697
Registration: Aug 29, 2019

Naphazoline Hydrochloride Nasal Drops

Approval Number: 国药准字H20194065
Registration: Aug 29, 2019

Concentrated Divitamins and Sodium Phosphate Syrup

Approval Number: 国药准字H20194066
Registration: Aug 29, 2019

Naoluotong Jiaonang

Approval Number: 国药准字Z44021297
Registration: Aug 28, 2019

N/A

Approval Number: 国药准字Z44021452
Registration: Aug 28, 2019

Inosine Tablets

Approval Number: 国药准字H44021777
Registration: Aug 28, 2019

Carbocysteine Tablets

Approval Number: 国药准字H44021792
Registration: Aug 28, 2019

蛤蚧大补胶囊

Approval Number: 国药准字Z44020146
Registration: Aug 28, 2019

Ceftazidime for Injection

Approval Number: 国药准字H20046163
Registration: Aug 28, 2019

妇康宝合剂

Approval Number: 国药准字Z44022555
Registration: Aug 28, 2019

湿润烧伤膏

Approval Number: 国药准字Z20000004
Registration: Aug 28, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.